<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;padding-top: 25px;;'>ME</div>
MEDTECHNICA is trading at 1679.00 as of the 26th of May 2020, which is 1.82 percent up since the beginning of the trading day. The stock's open price was 1649.0. Equity ratings for MEDTECHNICA are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 26th of February 2020 and ending today, the 26th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores


Medtechnica Ltd. operates as a distributor and service provider of medical equipment in Israel. The company was founded in 1953 and is based in Petah Tikva, Israel. MEDTECHNICA operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. more on MEDTECHNICA
Chief Executive OfficerMoshe BenshaulView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
MEDTECHNICA (MEDI) is traded on Tel Aviv Stock Exchange in Israel and employs 11 people. The company currently falls under 'Small-Cap' category with current market capitalization of 200.61 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MEDTECHNICA's market, we take the total number of it shares issued and multiply it by the MEDTECHNICA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. MEDTECHNICA operates under Healthcare sector and is part of Medical Devices industry. The entity has 0 outstanding shares. MEDTECHNICA has accumulated about 49.99 M in cash with 24.38 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.47.
Check MEDTECHNICA Probability Of Bankruptcy

MEDTECHNICA Stock Price Odds Analysis

Odds Down 1679.0HorizonTargetOdds Up 1679.0
75.44%30 days
Based on normal probability distribution, the odds of MEDTECHNICA to move above current price in 30 days from now is about 24.44 (This MEDTECHNICA probability density function shows the probability of MEDTECHNICA Stock to fall within a particular range of prices over 30 days) .


MEDTECHNICA Stock Against Markets

View Currently Related Equities

MEDTECHNICA Corporate Directors

Reuven Levin Director of Marketing
Tamar Galili Director
Saul Yemal External Director
Additionally, see Stocks Correlation. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page